Market capitalization | $6.27m |
Enterprise Value | $15.12m |
P/E (TTM) P/E ratio | negative |
EV/Sales (TTM) EV/Sales | 0.40 |
P/S ratio (TTM) P/S ratio | 0.17 |
P/B ratio (TTM) P/B ratio | 1.42 |
Revenue growth (TTM) Revenue growth | -4.28% |
Revenue (TTM) Revenue | $37.76m |
EBIT (operating result TTM) EBIT | $-10.78m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
2 Analysts have issued a IM Cannabis Corp forecast:
2 Analysts have issued a IM Cannabis Corp forecast:
Sep '24 |
+/-
%
|
||
Revenue | 38 38 |
4%
4%
|
|
Gross Profit | 4.86 4.86 |
47%
47%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -11 -11 |
15%
15%
|
Net Profit | -9.47 -9.47 |
67%
67%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.
Head office | Canada |
CEO | Oren Shuster |
Employees | 95 |
Founded | 1980 |
Website | imcannabis.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.